Request for Covid-19 Impact Assessment of this Report
Over the past few years, there has been a growing trend towards more frequent use of cell-based assays for drug discovery, especially since drug development is a billion-dollar business. Cell-based assays refer to any of number of different experiments based on the use of live cells. This is a general definition and can include a variety of assays that measure cell proliferation, toxicity, motility, production of a measurable product, and morphology.
Market Dynamics
The market has been gaining growth from many factors such as ubiquity of numerous chronic diseases, government support for the research and development activities, and improving healthcare infrastructure in developing countries in Asia Pacific. While, the factors challenging the wellbeing of the global cell based assays market are the curtailment on the usage of reagents and high cost of instruments.
Market Segmentation
Based on Products:
> Consumables
> Instruments
> Services
> Software
Based on End Users:
> Biopharmaceutical industries
> Contract research organizations
> Academic and research institutions
Based on Applications:
> Drug discovery
> Basic research
> ADME studies
> Predictive toxicology
> Other segments
Regional/Geographical Analysis
The cell-based assays market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is expected to dominate the cell-based assays market. The large market share of the region is credited to the growing availability of funds for research and the increase in drug discovery activities in North America. More than one application exists for using cell-based assays, where a large percentage of European-based companies are focussing on "biological pathway studies", "assay development", and "drug target identification and screening”.
Opportunities
. Increasing adoption of cell-based consumables by prominent biopharmaceutical companies and growing number of contact research organizations are some of the factors reflecting positively on this market. Currently, pharmaceutical and biotechnology companies serve the maximum demand, which reflects growing adoption of cell-based assays for drug discovery by the end users, especially in the developed countries within North America and Europe.
Key Players
Becton, Dickinson and Company, GE Healthcare, Cell Signaling Technology, Life Technologies Corporation, Danahar Corporation, Cisbio Bioassays, Merck KGaA, Discoverx Corporation, Thermo Fisher Scientific Inc., Perkinelmer Inc., Promega Corporation, Proqinase GmbH, Enzo Life Sciences, Inc., Charles River Laboratories International, Inc., Biospherix, Ltd., Essen Bioscience, Marine Biological Laboratory, Miltenyi Biotec, Bioagilytix Labs., Lonza, Aurelia Bioscience Ltd., Selexis SA, Cell Biolabs, Inc., Biotek Instruments, Inc., Qgel SA.
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...